Literature DB >> 34038186

Increased excitation-inhibition balance and loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction.

Shekib A Jami1, Scott Cameron1, Jonathan M Wong1, Emily R Daly1, A Kimberley McAllister1,2,3, John A Gray1,3.   

Abstract

There is substantial evidence that both N-methyl-D-aspartate receptor (NMDAR) hypofunction and dysfunction of GABAergic neurotransmission contribute to schizophrenia, though the relationship between these pathophysiological processes remains largely unknown. Although models using cell-type-specific genetic deletion of NMDARs have been informative, they display overly pronounced phenotypes extending beyond those of schizophrenia. Here, we used the serine racemase knockout (SRKO) mice, a model of reduced NMDAR activity rather than complete receptor elimination, to examine the link between NMDAR hypofunction and decreased GABAergic inhibition. The SRKO mice, in which there is a >90% reduction in the NMDAR coagonist d-serine, exhibit many of the neurochemical and behavioral abnormalities observed in schizophrenia. We found a significant reduction in inhibitory synapses onto CA1 pyramidal neurons in the SRKO mice. This reduction increases the excitation/inhibition balance resulting in enhanced synaptically driven neuronal excitability without changes in intrinsic excitability. Consistently, significant reductions in inhibitory synapse density in CA1 were observed by immunohistochemistry. We further show, using a single-neuron genetic deletion approach, that the loss of GABAergic synapses onto pyramidal neurons observed in the SRKO mice is driven in a cell-autonomous manner following the deletion of SR in individual CA1 pyramidal cells. These results support a model whereby NMDAR hypofunction in pyramidal cells disrupts GABAergic synapses leading to disrupted feedback inhibition and impaired neuronal synchrony.NEW & NOTEWORTHY Recently, disruption of excitation/inhibition (E/I) balance has become an area of considerable interest for psychiatric research. Here, we report a reduction in inhibition in the serine racemase knockout mouse model of schizophrenia that increases E/I balance and enhances synaptically driven neuronal excitability. This reduced inhibition was driven cell-autonomously in pyramidal cells lacking serine racemase, suggesting a novel mechanism for how chronic NMDA receptor hypofunction can disrupt information processing in schizophrenia.

Entities:  

Keywords:  E/I balance; GABA; NMDA receptor; SRR; inhibition

Mesh:

Substances:

Year:  2021        PMID: 34038186      PMCID: PMC8325603          DOI: 10.1152/jn.00661.2020

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  142 in total

1.  NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

2.  Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia.

Authors:  Kenji Kirihara; Anthony J Rissling; Neal R Swerdlow; David L Braff; Gregory A Light
Journal:  Biol Psychiatry       Date:  2012-02-22       Impact factor: 13.382

3.  Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death.

Authors:  D Forrest; M Yuzaki; H D Soares; L Ng; D C Luk; M Sheng; C L Stewart; J I Morgan; J A Connor; T Curran
Journal:  Neuron       Date:  1994-08       Impact factor: 17.173

4.  Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition.

Authors:  H Wigström; B Gustafsson
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

5.  GluR- and TrkB-mediated maturation of GABA receptor function during the period of eye opening.

Authors:  Christian Henneberger; René Jüttner; Sonja A Schmidt; Jan Walter; Jochen C Meier; Thomas Rothe; Rosemarie Grantyn
Journal:  Eur J Neurosci       Date:  2005-01       Impact factor: 3.386

6.  An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.

Authors:  Darrick T Balu; Yan Li; Shunsuke Takagi; Kendall Taylor Presti; Teniel S Ramikie; Jerri M Rook; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn; Vadim Y Bolshakov; Joseph T Coyle
Journal:  Neuropsychopharmacology       Date:  2016-01-07       Impact factor: 7.853

7.  Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.

Authors:  Gary E Duncan; Sheryl S Moy; Antonio Perez; Dawn M Eddy; Wendy M Zinzow; Jeffrey A Lieberman; John N Snouwaert; Beverly H Koller
Journal:  Behav Brain Res       Date:  2004-08-31       Impact factor: 3.332

8.  The cell-autonomous role of excitatory synaptic transmission in the regulation of neuronal structure and function.

Authors:  Wei Lu; Eric A Bushong; Tiffany P Shih; Mark H Ellisman; Roger A Nicoll
Journal:  Neuron       Date:  2013-05-08       Impact factor: 17.173

9.  A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Margarita M Behrens; Anthony A Grace
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

10.  Serine Racemase Deletion Affects the Excitatory/Inhibitory Balance of the Hippocampal CA1 Network.

Authors:  Eva Ploux; Valentine Bouet; Inna Radzishevsky; Herman Wolosker; Thomas Freret; Jean-Marie Billard
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

View more
  3 in total

1.  Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction.

Authors:  David D Aguilar; Leana K Radzik; Felipe L Schiffino; Oluwarotimi O Folorunso; Mark R Zielinski; Joseph T Coyle; Darrick T Balu; James M McNally
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.996

2.  Reduced d-serine levels drive enhanced non-ionotropic NMDA receptor signaling and destabilization of dendritic spines in a mouse model for studying schizophrenia.

Authors:  Deborah K Park; Samuel Petshow; Margarita Anisimova; Eden V Barragan; John A Gray; Ivar S Stein; Karen Zito
Journal:  Neurobiol Dis       Date:  2022-05-20       Impact factor: 7.046

Review 3.  Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.

Authors:  Andrea de Bartolomeis; Licia Vellucci; Mark C Austin; Giuseppe De Simone; Annarita Barone
Journal:  Biomolecules       Date:  2022-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.